Adjuvant therapy in type 1 diabetes mellitus.
Adult
Diabetes Mellitus, Type 1
/ drug therapy
Diabetic Nephropathies
/ prevention & control
Female
Glycated Hemoglobin
/ analysis
Heart Failure
/ prevention & control
Humans
Hypoglycemic Agents
/ therapeutic use
Male
Sodium-Glucose Transporter 2
/ metabolism
Sodium-Glucose Transporter 2 Inhibitors
/ therapeutic use
adjuvant therapy
type 1 diabetes mellitus
Journal
Endokrynologia Polska
ISSN: 2299-8306
Titre abrégé: Endokrynol Pol
Pays: Poland
ID NLM: 0370674
Informations de publication
Date de publication:
2021
2021
Historique:
received:
13
12
2020
accepted:
14
12
2020
pubmed:
24
2
2021
medline:
21
10
2021
entrez:
23
2
2021
Statut:
ppublish
Résumé
Not required for Clinical Vignette.
Identifiants
pubmed: 33619718
pii: VM/OJS/J/72299
doi: 10.5603/EP.a2021.0003
doi:
Substances chimiques
Glycated Hemoglobin A
0
Hypoglycemic Agents
0
Sodium-Glucose Transporter 2
0
Sodium-Glucose Transporter 2 Inhibitors
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM